Clinical experience with transdermal fentanyl for the treatment of cancer pain in Germany

Keio Journal of Medicine

Volumn 53, Issue 1, 2004, Pages 23-29

  Radbruch, Lukas ^a   Elsner, Frank ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cancer pain; Constipation; Germany; Transdermal fentanyl

Indexed keywords

BUPRENORPHINE; FENTANYL; HYDROMORPHONE; LAXATIVE; MORPHINE; OPIATE; OXYCODONE;

ANALGESIA; BIOAVAILABILITY; CANCER PAIN; CLINICAL PRACTICE; CONFERENCE PAPER; CONSTIPATION; CONTROLLED STUDY; CONVULSION; DEATH; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; GASTROINTESTINAL SYMPTOM; GERMANY; HALLUCINATION; HUMAN; NAUSEA; NEUROTOXICITY; PAIN; PLEURISY; PNEUMONIA; PRURITUS; RESPIRATION DEPRESSION; TITRIMETRY; VOMITING; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; CLINICAL TRIALS; CONSTIPATION; FENTANYL; GERMANY; HUMANS; NARCOTICS; NEOPLASMS; PAIN; TIME FACTORS;

EID: 1842634101     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.53.23     Document Type: Conference Paper

References (16)

1. World Health Organisation, Cancer Pain Relief, Geneva, World Health Organisation, 1986
2. Zech DF, Grond SU, Lynch J, Dauer HG, Stollenwerk B, Lehmann KA: Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients. Pain 1992; 50: 293-301
3. Grond S, Zech D, Lehmann KA, Radbruch L, Breitenbach H, Hertel D: Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain 1997; 69: 191-198
4. Ahmedzai S, Brooks D: Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage 1997; 13: 254-261
5. Donner B, Zenz M, Tryba M, Strumpf M: Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996; 64: 527-534
6. Radbruch L, Sabatowski R, Loick G, Kulbe C, Kasper M, Grond S, Lehmann KA: Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med 2000; 14: 111-119
7. Nightingale SL: From the Food and Drug Administration. JAMA 1990; 264: 1802
8. Radbruch L, Sabatowski R, Petzke F, Brunsch-Radbruch A, Grond S, Lehmann KA: Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med 2001; 15: 309-321
9. Sabatowski R, Schwalen S, Rettig K, Herberg KW, Kasper SM, Radbruch L: Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage 2003; 25: 38-47
10. Lehmann KA, Radbruch L, Gockel HH, Neighbors D, Nuyts G: Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine. Eur J Healh Econom 2002; 3: 111-119
11. Radbruch L, Nauck F, Sabatowski R: Germany: Cancer pain and palliative care - current situation. J Pain Symptom Manage 2002; 24: 183-187
12. Sabatowski R, Arens ER, Waap I, Radbruch L: Cancer pain management in Germany - results and analysis of a questionnaire Schmerz 2001; 15: 241-247 (In Germany)
13. Ensink FBM, Bautz MT, Voß MC, Görlitz A, Hanekop GG: Cancer pain management in Germany - results and analysis of a questionnaire. Schmerz; in print (In Germany)
14. Böger RH, Schmidt G: Analgetika. In: Schwabe, U, Paffrath D, eds, Arneiverordnungsreport 2001, Berlin, Springer, 2001; 89-102
15. Schmidt G: Analgetika. In: Schwabe U, Paffrath D, eds, Arneiverordnungsreport 1991, Stuttgart, Gustav Fischer Verlag, 1991; 20-31
16. Nauck F, Ostgathe C, Radbruch L, Bausewein C, Fuchs M, Lindena G, Neuwöhner K, Schulenberg D, Klaschik E: Drugs in Palliative Care - Results from a respresentative survey, Palliative Medicine; in print